This GLP-1 receptor agonist functions by: augmenting insulin release, abating glucagon secretion, retarding gastric emptying, diminishing appetite As a result, semaglutide is particularly helpful for individuals outside the ideal body mass index who are seeking to lose weight and improve their glycemic control
However, if you have documented moderate to severe obstructive sleep apnea alongside obesity, Zepbound may be covered under that indication
Copyright 2024, NielsenConsumer LLC.
TODAY (@TODAYshow) September 20, 2024 Several forces are now converging: Strong clinical evidence supporting GLP-1 effectiveness Rising patient demand for weight and metabolic health treatments Federal pressure to reduce drug prices Potential expansion of insurance coverage If coverage expands significantly, utilization will almost certainly rise further
Scientists continue to investigate how different receptor configurations contribute to distinct biological responses
If you experience recurrent storage issues, discuss alternative arrangements with your healthcare team, such as smaller prescription quantities or more frequent collections
